Law & Regulation

Indian companies will be free to continue making less expensive generic drugs, much of which flow to the developing world, after a court rejected a challenge to the patent law on Monday. Read More

An influential Republican senator says he will propose legislation requiring drug makers to disclose the payments they make to doctors for services like consulting, lectures and attendance at seminars. Read More

Mattel, the maker of Barbie dolls and Hot Wheels cars, is recalling nearly one million toys in the United States today because the products' surfaces are covered in lead paint. According to Mattel, all the toys were made by a contract manufacturer in China. Read More

In the wake of the multiple scandals over tainted Chinese food and drug exports in recent months, Chinese goods now have an indelible image of being not just cheap, but life-threatening as well. But the fact that wrongly labelled foods, liquor and pharmaceuticals have routinely sickened and even killed people en masse in China has been largely overlooked. Read More

The Beijing Olympic Organizing Committee said it was taking corrective measures after a monthlong investigation found that four factories making Olympic merchandise were guilty of labor violations. Read More

An ambush in Iraq last November left four Americans missing and a string of questions about the firm they worked for. Read More

Follow-up studies on a cleanup effort at the site of a former Ford car factory have shown that there is still a great deal of toxins left in the soil. Read More

Political fortunes and high costs have forced some presidential candidates to switch from using chartered private jets to those of corporations, including John McCain, who had previously sponsored a bill limiting use of corporate jets by candidates. Read More

One of the largest American contractors working in Iraq, Bechtel National, met its original objectives on fewer than half of the projects it received as part of a $1.8 billion reconstruction contract, while most of the rest were canceled, reduced in scope or never completed as designed, federal investigators have found in a report released yesterday. Read More

The Food and Drug Administration will ask a panel of outside medical experts Monday whether it thinks GlaxoSmithKline PLC's diabetes drug Avandia should remain on the U.S. market. Read More